Announcement of The Consolidated Financial Report for The 1st Quarter of 2024
2024.5.7
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2024/05/07 | Time of announcement | 16:54:59 |
| Subject | Announcement of The Consolidated Financial Report for The 1st Quarter of 2024 | ||||
| Date of events | 2024/05/07 | To which item it meets | paragraph 31 | ||
| Statement | 1.Date of the board of directors submitted or approved:2024/05/07 2.Date of the audit committee approved:2024/05/07 3.Start and end dates of financial reports or unaudited financial information of the reporting period:2024/01/01~2024/03/31 4.Operating revenue accumulated from 1/1 to end of the period (thousand NTD):1,273,605 5.Gross profit (loss) from operations accumulated from 1/1 to end of the period (thousand NTD):770,920 6.Net operating income (loss) accumulated from 1/1 to end of the period (thousand NTD):309,901 7.Profit (loss) before tax accumulated from 1/1 to end of the period (thousand NTD):368,054 8.Profit (loss) accumulated from 1/1 to end of the period (thousand NTD):294,726 9.Profit (loss) during the period attributable to owners of parent accumulated from 1/1 to end of the period (thousand NTD):280,771 10.Basic earnings (loss) per share accumulated from 1/1 to end of the period (NTD):1.13 11.Total assets end of the period (thousand NTD):10,074,106 12.Total liabilities end of the period (thousand NTD):3,953,247 13.Equity attributable to owners of parent end of the period (thousand NTD):5,486,332 14.Any other matters that need to be specified:None |
||||